172 related articles for article (PubMed ID: 14632631)
1. Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer.
Simpson PT; Shoker BS; Barraclough R; Halliwell N; Rudland PS; Sibson DR; Davies MP
Int J Exp Pathol; 2003 Aug; 84(4):173-84. PubMed ID: 14632631
[TBL] [Abstract][Full Text] [Related]
2. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours.
Davies MP; Rudland PS; Robertson L; Parry EW; Jolicoeur P; Barraclough R
Oncogene; 1996 Oct; 13(8):1631-7. PubMed ID: 8895508
[TBL] [Abstract][Full Text] [Related]
3. S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis.
Yuan W; Goldstein LD; Durinck S; Chen YJ; Nguyen TT; Kljavin NM; Sokol ES; Stawiski EW; Haley B; Ziai J; Modrusan Z; Seshagiri S
Breast Cancer Res; 2019 Dec; 21(1):152. PubMed ID: 31881983
[TBL] [Abstract][Full Text] [Related]
4. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
5. Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors.
Grum-Schwensen B; Klingelhöfer J; Grigorian M; Almholt K; Nielsen BS; Lukanidin E; Ambartsumian N
Cancer Res; 2010 Feb; 70(3):936-47. PubMed ID: 20103644
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional down-regulation of the metastasis-inducing S100A4 (p9Ka) in benign but not in malignant rat mammary epithelial cells by GC-factor.
Chen D; Davies MP; Rudland PS; Barraclough R
J Biol Chem; 1997 Aug; 272(32):20283-90. PubMed ID: 9242709
[TBL] [Abstract][Full Text] [Related]
7. Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens.
Nikitenko LL; Lloyd BH; Rudland PS; Fear S; Barraclough R
Int J Cancer; 2000 Apr; 86(2):219-28. PubMed ID: 10738249
[TBL] [Abstract][Full Text] [Related]
8. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis.
Jenkinson SR; Barraclough R; West CR; Rudland PS
Br J Cancer; 2004 Jan; 90(1):253-62. PubMed ID: 14710237
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified mouse models to study the role of metastasis-promoting S100A4(mts1) protein in metastatic mammary cancer.
Ambartsumian N; Grigorian M; Lukanidin E
J Dairy Res; 2005; 72 Spec No():27-33. PubMed ID: 16180718
[TBL] [Abstract][Full Text] [Related]
10. Calcium-binding protein S100A4 in health and disease.
Barraclough R
Biochim Biophys Acta; 1998 Dec; 1448(2):190-9. PubMed ID: 9920410
[TBL] [Abstract][Full Text] [Related]
11. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.
Jolicoeur P; Bouchard L; Guimond A; Ste-Marie M; Hanna Z; Dievart A
Biochem Soc Symp; 1998; 63():159-65. PubMed ID: 9513720
[TBL] [Abstract][Full Text] [Related]
12. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
13. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.
Campbell MJ; Wollish WS; Lobo M; Esserman LJ
In Vitro Cell Dev Biol Anim; 2002 Jun; 38(6):326-33. PubMed ID: 12513120
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
[TBL] [Abstract][Full Text] [Related]
16. Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells.
Lloyd BH; Platt-Higgins A; Rudland PS; Barraclough R
Oncogene; 1998 Jul; 17(4):465-73. PubMed ID: 9696040
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
Fleming NI; Trivett MK; George J; Slavin JL; Murray WK; Moseley JM; Anderson RL; Thomas DM
Cancer Res; 2009 Sep; 69(18):7473-9. PubMed ID: 19723659
[TBL] [Abstract][Full Text] [Related]
18. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
19. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
20. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
